51161569 Montelukast sodium

Definition

UNSPSC 51161569

This classification denotes an anti-asthmatic agent with the molecular formula C35H35ClNO3S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U1O3J18SFL, chemically known as cyclopropaneacetic acid, 1-((((1r)-1-(3-((1e)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, monosodium salt but more generally known as montelukast sodium, which bears US NIH Compound Identifier 5281041. European Medicines Agency schedules Montelukast sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03324MIG. Most nations, for tariff and trade purposes, schedule montelukast sodium under HS 29334990 and SITC 51575. As of Q4 2014, MONTELUKAST SODIUM remains US FDA's Preferred Term for this commodity. Montelukast sodium bears US NLM identifiers UMLS ID C0380447 and NCI Concept Code C47625. SMILES: CC(C)(C1CCCCC1CC[C@H](C2CCCC(C2)/C=C/C3CCC4CCC(CC4N3)CL)SCC5(CC5)CC(=O)[O-])O.[NA+].

Same parent

Under 51161500 · 56

51161513 Diprophylline or dyphylline Commodity 51161515 Montelukast Commodity 51161517 Zileuton Commodity 51161518 Pranlukast Commodity 51161519 Carmoterol Commodity 51161521 Cilomilast Commodity 51161524 Tiotropium Commodity 51161526 Dazoquinast Commodity 51161527 Ablukast Commodity 51161528 Acitazanolast Commodity 51161529 Acreozast Commodity 51161530 Amipizone Commodity 51161531 Arofylline Commodity 51161532 Binizolast Commodity 51161533 Isbufylline Commodity 51161534 Denbufylline Commodity 51161535 Dimabefylline Commodity 51161536 Doxofylline Commodity 51161537 Enofelast Commodity 51161538 Eprozinol Commodity 51161539 Etamiphyllin or etamiphylline Commodity 51161540 Flufylline Commodity 51161541 Fluprofylline Commodity 51161542 Furafylline Commodity 51161543 Oxarbazole Commodity 51161544 Lomifylline Commodity 51161545 Melquinast Commodity 51161546 Midaxifylline Commodity 51161547 Motapizone Commodity 51161548 Nepadutant Commodity 51161549 Nestifylline Commodity 51161550 Ontazolast Commodity 51161551 Perbufylline Commodity 51161552 Pirolate Commodity 51161553 Proxyphylline Commodity 51161554 Ritolukast Commodity 51161555 Seratrodast Commodity 51161556 Tomelukast Commodity 51161557 Zardaverine Commodity 51161558 Nivimedone Commodity 51161559 Cromitrile Commodity 51161560 Nisbuterol Commodity 51161561 Pirquinozol Commodity 51161562 Norethindrone and ethinyl estradiol combination Commodity 51161563 Zafirlukast Commodity 51161564 Ablukast sodium Commodity 51161565 Acitazanolast hydrate Commodity 51161566 Cromitrile sodium Commodity 51161567 Eprozinol dihydrochloride Commodity 51161568 Eprozinol hydrochloride Commodity 51161569 Montelukast sodium You are here 51161570 Nisbuterol mesilate or mesylate Commodity 51161571 Nivimedone sodium Commodity 51161572 Nivimedone sodium anhydrous Commodity 51161573 Pranlukast hydrate Commodity 51161574 Tiotropium bromide Commodity

Activities that produce or sell this

KBLI · 9

Inherited from family 51160000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47111 Perdagangan Eceran Berbagai Macam Barang yang Utamanya Makanan, Minuman, atau Tembakau dengan Sistem Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class